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Abstract
Background: Near-infrared fluorescence laparoscopy after intravenous indocyanine green (ICG) administration
has been proposed as a promising surgical imaging technique for real-time visualization of the extrahepatic bile
ducts and arteries in clinical laparoscopic cholecystectomies. However, optimization of this new technique with
respect to the imaging system combined with the fluorophore is desirable. The performance of a preclinical
near-infrared dye, CW800-CA, was compared with that of ICG for near-infrared fluorescence laparoscopy of
the cystic duct and artery in pigs.
Materials and Methods: Laparoscopic cholecystectomy was performed in six pigs (average weight, 35 kg) using
a commercially available laparoscopic fluorescence imaging system. The fluorophores CW800-CA and ICG (both
800nm fluorescent dyes) were administered by intravenous injection in four and two pigs, respectively. CW800-
CA was administered in three different doses (consecutively 0.25, 1, and 3mg); ICG was intravenously injected
(2.5mg) for comparison. Intraoperative recognition of the biliary structures was recorded at set time points. The
target-to-background ratio was determined to quantify the fluorescence signal of the designated tissues.
Results: A clinically proven dose of 2.5mg of ICG resulted in a successful fluorescence delineation of both the
cystic duct and artery. In the CW800-CA-injected pigs a clear visualization of the cystic duct and artery was
obtained after administration of 3mg of CW800-CA. Time from injection until fluorescence identification of the
cystic duct was reduced when CW800-CA was used compared with ICG (11.5 minutes versus 21.5 minutes,
respectively). CW800-CA provided clearer illumination of the cystic artery, in terms of target-to-background ratio.
Conclusions: As well as ICG, CW800-CA can be applied for fluorescence identification of the cystic artery and
duct using a commercially available laparoscopic fluorescence imaging system. Fluorescence cholangiography
of the cystic duct can be obtained earlier after intravenous injection of CW800-CA, compared with ICG. These
findings increase the possibilities of use and of optimization of this imaging technique.
Introduction
In patients with symptomatic cholecystolithiasis and/orcholecystitis, laparoscopic cholecystectomy is currently
the standard of care in most Western countries. Although an
incidence of only 0.7% is reported for bile duct injury during
laparoscopic cholecystectomy, it constitutes a severe com-
plication that may result in increased long-term morbidity
and, as a consequence, increased costs. Furthermore, it may
negatively affect the quality of life of patients.1–3
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Near-infrared fluorescence imaging after intravenous in-
docyanine green (ICG) administration is an innovative and
promising laparoscopic imaging method for intraopera-
tive visualization of crucial anatomical structures.4 Several
clinical pilot studies have demonstrated its usefulness and
feasibility for real-time intraoperative identification of ex-
trahepatic bile ducts and arteries to assist in safe and time-
efficient gallbladder removal. However, this new technique
needs optimization with respect to imaging systems and
injected fluorophores.
CW800-CA is a relatively new fluorophore, which like
ICG also has 800 nm fluorescent capabilities. It has not
yet been cleared by the U.S. Food and Drug Adminis-
tration for clinical use but has a low risk of toxicity equal
to that of ICG and incorporates favorable characteris-
tics for fluorescence imaging of vital anatomy.5,6 The
most advantageous characteristic of CW800-CA is its
increased hydrophilicity, resulting in improved secretion
into bile and earlier fluorescence illumination of the bile
ducts.5,6
This study was conducted to assess the performance of
CW800-CA versus the clinically already available ICG for
near-infrared fluorescence laparoscopy of the cystic duct and
cystic artery in pigs using a commercially available laparo-
scopic fluorescence imaging system.
Materials and Methods
This study was conducted at the central animal facilities of
Maastricht University (Maastricht, The Netherlands). Ani-
mals were used in compliance with the regulations of the
Dutch legislation for animal research, and the study protocol
was approved by the Animal Ethics Committee of Maastricht
University (project number 2012-098). A pig model was
chosen because of its similarity with human anatomy. Six
female Dutch Landrace pigs, weighing an average of 35 kg,
were used for the current study.
Laparoscopic fluorescence imaging system
A commercially available laparoscopic fluorescence im-
aging system (Karl Storz GmbH & Co. KG, Tuttlingen,
Germany) was used. The system includes a plasma light
guide and 30 10-mm laparoscope applicable for both white
light and near-infrared fluorescence imaging. A foot pedal
allows the surgeon to easily switch back and forth from
conventional imaging to fluorescence imaging. Procedures
were digitally recorded.
Preparation of near-infrared fluorophore
In these animal experiments, the system, which was pri-
marily developed for ICG imaging, was now also tested for
its feasibility for real-time intraoperative fluorescence visu-
alization of biliary anatomy (cystic duct and cystic artery)
after intravenous administration of the preclinical fluorescent
dye CW800-CA (a carboxylate of the near-infrared fluor-
ophore IRDye 800CW [LI-COR Biosciences, Lincoln,
NE]). CW800-CAwas diluted in a sterile phosphate-buffered
saline (PBS) solution.
Surgical technique
Premedication comprised intramuscular injection of
azaperone (3mg/kg), ketamine (10mg/kg), and atropine
(0.05mg/kg). Anesthesia was induced with intravenous ad-
ministration of thiopental (10–15mg/kg), followed by in-
tubation, and maintained with the animal under anesthesia
with isoflurane (depending on effect) and oxygen (20–40mL/
kg/minute). Thereafter a laparoscopy was performed.
In each pig a laparoscopic cholecystectomy was per-
formed, according to the Dutch Guidelines and best practice
for laparoscopic cholecystectomy,7 which is based on the
Critical View of Safety technique.
One experiment per animal was conducted. In the first two
pigs, 1mL of ICG (2.5mg/mL of Infracyanine; SERB,
Paris, France) was injected intravenously. This dose has
proven sufficient for clinical use.8 For the third experiment
(pig number 3), 5mg of CW800-CA was diluted in 20mL of
PBS solution (0.25mg/mL). One millliliter of this solution
(0.25mg) was intravenously administered. For the subse-
quent three experiments, 5mg of CW800-CA was diluted in
5mL of PBS solution (1mg/mL). Next, 1mL (1.0mg) of the
solution was injected in pig number 4. Three milliliters
(3.0mg) of the solution was administered in pigs numbers 5
and 6.
Fluorescence imaging was obtained directly after dye
injection and subsequently every 5–10 minutes. Intra-
operatively the researcher systematically recorded on a form
whether the localization of cystic duct or cystic artery could
be identified at set time points, comparing the WL camera
mode with the ICGmode. For agreement on the identification
of the aforementioned structures, the attending surgeon was
consulted. A structure was scored as ‘‘identified’’ if its lo-
calization was confirmed with great certainty by the experi-
enced surgeon. An overview of the six experiments is
presented in Table 1.




















1 ICG 2.5 1.0 Yes Yes 20
2 ICG 2.5 1.0 Yes Yes 22
3 CW800-CA 0.25 1.0 No No —
4 CW800-CA 1.0 1.0 No No —
5 CW800-CA 1.0 3.0 Yes Yes 11
6 CW800-CA 1.0 3.0 Yes Yes 12
ICG, indocyanine green.
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Quantitative fluorescence image analysis
For objective assessment of the degree of fluores-
cence illumination in the extrahepatic bile ducts and ar-
tery, OsiriX version 5.5.1 imaging (open source) software
was used. The fluorescence images were analyzed by de-
termining target-to-background ratio (TBR). TBR was
defined as the mean fluorescence intensity (FI) (in arbi-
trary units) of three point regions of interest in the target
(i.e., cystic duct or cystic artery) minus the mean FI of
three background regions of interest in the liver hilum,
divided by the mean FI of the three background regions
of interest in the liver hilum, according to the following
equation:
TBR¼ (FI of target FI of background)=FI of background
Results
In the first two experiments ICG fluorescence lapa-
roscopy for identification of the cystic artery (Fig. 1B)
and cystic duct (Fig. 2B) was successfully conducted.
The CW800-CA dosage in experiments 3 (0.25mg) and 4
(1.0 mg) was insufficient to obtain fluorescence delineation
of these structures. Using a dose of 3mg of CW800-CA in
the last two experiments led to clear visualization of the
cystic artery (Fig. 1D) and cystic duct (Fig. 2D) in both
pigs. Observations of the six experiments are summarized
in Table 1.
TBR
The TBR values of the cystic artery versus gallbladder and
the cystic artery versus liver parenchyma in the arterial phase
after ICG injection were -0.6 and 0.5, respectively (pig
2, – 30 seconds after dye administration [Fig. 1B]). These
data confirm the inability of ICG-based imaging to identify
the cystic artery when positioned directly on the liver pa-
renchyma. After injection of CW800-CA, the TBR values of
the cystic artery versus gallbladder and the cystic artery
versus liver parenchyma were 1.1 and 1.7 (– 30 seconds after
dye administration [Fig. 1D]). This indicates a clear recog-
nition of the cystic artery when positioned above liver pa-
renchyma and the gallbladder if CW800-CA is used. The
TBR values of the cystic duct versus liver parenchyma were
3.2 for ICG (Fig. 2B) and 2.3 for CW800-CA (Fig. 2D).
Complications
No peri- or postoperative complications regarding the
extrahepatic bile ducts occurred. None of the pigs developed
any adverse reactions to the injected ICG or CW800-CA. No
interference with intraoperative monitoring of the saturation
of peripheral oxygen was observed.
Discussion
In the present study the feasibility of fluorescence imaging
of the cystic duct and artery using CW800-CA and a com-
mercially available laparoscopic fluorescence imaging sys-
tem was investigated. To assess the performance of this
preclinical contrast agent, ICG was used for comparison.
CW800-CA provided comparable visualization of the course
of the cystic duct and better identification of the cystic artery.
With respect to the fluorophores investigated in this study,
it is important to address the following characteristics. ICG
is a disulfonated heptamethine indocyanine that is Food
and Drug Administration–approved for clinical use. After in-
travenous injection, it is rapidly cleared from the blood by the
liver and transported into the bile. Consequently, intravenously
injected ICG is applicable for cholangiography. CW800-CA is
a carboxylate of IRDye 800CW, a tetrasulfonated hepta-
methine indocyanine. Emission of this dye is quite similar to
that of ICG (also at 800 nm). However, after intravenous in-
jection, it is rapidly cleared not only by the liver and excreted
into bile, but also by the kidneys and excreted into the urine. As
a result this dye is usable for imaging of the biliary anatomy
and of the ureters.9
Previously Tanaka et al.5 tested ICG and CW800-CA for
bile duct imaging in rats and pigs during open surgery.
CW800-CA proved to be more selective, as ICG suffered
from lack of efficient secretion into bile from the liver. In
addition, CW800-CA was excreted into bile in a predomi-
nantly unmetabolized form, which increases the rapidity
and signal intensity by which images can be obtained after
administration.
In the present study, the CW800-CA dosage in the first
experiment was based on the report by Tanaka et al.5 A dose
of 7.5 lg/kg of body weight appeared not sufficient for lap-
aroscopic fluorescence detection of the cystic duct and artery.
With a significantly higher dose (85lg/kg) of the injected
dye, clear visualization of the course of the cystic duct and
artery was obtained in this study.
Furthermore, from this study it was noted that time from
injection until fluorescence identification of the cystic duct
was reduced when CW800-CA was used compared with ICG
(11.5 minutes versus 21.5 minutes, respectively). Based on
TBR values, this study demonstrates the ability of identifying
the cystic duct after injection of both fluorophores. Regarding
arterial fluorescence imaging, background signal (i.e., dye
uptake by the liver parenchyma) was larger when ICG was
used, compared with CW800-CA. Therefore recognition of
the cystic artery might be easier with CW800-CA.
Besides laparoscopic cholecystectomy, fluorescence im-
aging of crucial biliary structures might be beneficial in
other (laparoscopic) hepatopancreatobiliary surgical pro-
cedures as well. Possible applications of this technique
during hepatopancreatobiliary surgery include tumor de-
tection in liver and pancreas resections and real-time imaging
of intra- and extrahepatic bile ducts (and branches) of hepatic,
cystic, pancreatic, gastroduodenal, and pancreatoduodenal
arteries.10–12
Moreover, fluorescence imaging could be performed to
detect bile leakage during open and laparoscopic partial liver
resections. This complication after hepatectomy occurs in
approximately 8% of all patients undergoing partial liver
resection and is associated with greater postoperative mor-
tality and healthcare costs.13 Prevention of bile leakage after
hepatectomy therefore deserves attention. In a randomized
clinical trial that evaluated the use of ICG fluorescence
cholangiography to prevent postoperative bile leakage after
hepatic resections, the ability to detect leaking bile duct stumps
at the cut surface of the remnant liver, which were missed
by conventional bile leak tests, was demonstrated.14 Given its
pharmacokinetics, CW800-CA might prove to be even more
suitable for the detection of bile leakage.
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FIG. 2. Cystic duct delineation. (A and B) Snapshots taken during indocyanine green (ICG) fluorescence laparoscopy
experiments in pig 1. (A) The anatomical view of the gallbladder and liver hilum. (B) The associated fluorescence
cholangiogram of the gallbladder and cystic duct (the cystic duct is indicated by the arrow). The target-to-background
ratio is 3.2. (C and D) Result of CW800-CA fluorescence laparoscopy in pig 5: the anatomical view and the associ-
ated fluorescence delineation, respectively, of the cystic duct (the cystic duct is indicated by the arrow). The target-to-
background ratio is 2.3.
FIG. 1. Cystic artery imaging. (A and B) Snapshots taken during indocyanine green (ICG) fluorescence laparoscopy
experiments in pig 1. (A) The anatomical view of the gallbladder and liver hilum. (B) The associated ICG fluorescence
image of the cystic artery (the cystic artery is indicated by the arrow). The target-to-background ratio is 0.5. (C and D)
Fluorescence angiography using CW800-CA in pig 5: the anatomical view and the associated fluorescence delineation,
respectively, of the cystic artery (the cystic artery is indicated by the arrows). The target-to-background ratio is 1.7.
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Although this report only describes a small experimental
animal study and a large difference in dosage of CW800-CA,
the concept of fluorescence visualization of the cystic duct
and artery using CW800-CA has successfully been demon-
strated using a commercially available laparoscopic fluores-
cence imaging system. A clinical pilot study investigating
the feasibility of near-infrared fluorescence imaging using
CW800-CA in laparoscopic cholecystectomy is the next step.
Such a pilot study should focus on dose-finding of the ad-
ministered dye, as even a lower dose than 3mg/mL (used in
experiments 5 and 6) might be sufficient.
Conclusions
As well as ICG, CW800-CA can be applied for laparo-
scopic fluorescence identification of the cystic artery and duct
using a commercially available imaging system. Laparo-
scopic fluorescence cholangiography of the cystic duct can be
obtained earlier after intravenous injection of CW800-CA,
compared with ICG. With the availability of two instead of
one fluorophore, the possibilities increase to further optimize
the imaging capabilities of the presently available fluores-
cence systems. A dose-finding and clinical feasibility study
for CW800-CA is the next step.
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